http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111534586-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f01c96d9e6590eabe5e5e3409c346fb4 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81075e2c56d784e2f8e9d6f90613d294 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adea71258b443fec57aed24a002eb159 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feb34a9186c1dd20b7fd0262d45992a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76a5c9cd91824be2f866eecd2ece4064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d74ba5c4028280289e43420cc0b8a1a8 |
| publicationDate | 2020-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111534586-A |
| titleOfInvention | A kit and detection method for detecting CEA gene mutation in peripheral blood circulating tumor cells of patients with non-small cell lung cancer |
| abstract | The invention provides a kit and a detection method for detecting CEA gene mutation in peripheral blood circulating tumor cells of non-small cell lung cancer patients, belonging to the technical field of molecular biology. The kit includes Diluent, Destaining Solution, Staining Solution A, Staining Solution B, CEACAM5/6100μL, Goat Anti-Mouse IgG/HRP, SABC, 0.1% Triton X‑100, 0.3% H 2 O 2 , Reagent A, Reagent B. 6×PBS buffer. The detection method provided by the present invention can detect the expression of CEA in patients with advanced or recurrent non-small cell lung cancer without obtaining tissue samples by needle biopsy. The technique is minimally invasive and enables real-time detection. The method provided by the invention can avoid false positive results caused by edge effects that may occur in the dyeing process, has good stability, reduces cell loss and improves detection accuracy. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021213302-A1 |
| priorityDate | 2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 152.